Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia

NCT: NCT04827147 · COMPLETED

NCT IDNCT04827147
StatusCOMPLETED
Start Date2023-04-03
Completion2026-04-30
SponsorMassachusetts Eye and Ear Infirmary (OTHER)
First posted
Last updated

Brief Summary

This clinical trial will evaluate the efficacy of two types of high-power prism glasses that provide field of view expansion for patients with homonymous hemianopia (the complete loss of half the field of vision on the same side in both eyes).

Frequently Asked Questions

What is Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia?

Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia is a clinical trial registered under NCT04827147. Current status: COMPLETED.

What is the status of NCT04827147?

The current status of NCT04827147 (Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia) is: COMPLETED.

When did Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia start?

Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia started on 2023-04-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.